RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine.
BMC Infect Dis
; 22(1): 87, 2022 Jan 24.
Article
in En
| MEDLINE
| ID: mdl-35073866
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Antibody Formation
Type of study:
Prognostic_studies
Limits:
Aged
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
BMC Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2022
Document type:
Article
Affiliation country:
Hungary
Country of publication:
United kingdom